Squarepoint Ops LLC Sells 12,972 Shares of Simulations Plus, Inc. (NASDAQ:SLP)

Squarepoint Ops LLC reduced its stake in Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 52.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,625 shares of the technology company's stock after selling 12,972 shares during the period. Squarepoint Ops LLC owned approximately 0.06% of Simulations Plus worth $324,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Simulations Plus by 4.4% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,103 shares of the technology company's stock worth $254,000 after acquiring an additional 380 shares during the last quarter. Jones Financial Companies Lllp grew its position in Simulations Plus by 53.6% during the 4th quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company's stock worth $34,000 after acquiring an additional 427 shares during the last quarter. Pitcairn Co. grew its position in Simulations Plus by 10.8% during the 4th quarter. Pitcairn Co. now owns 7,310 shares of the technology company's stock worth $204,000 after acquiring an additional 711 shares during the last quarter. US Bancorp DE grew its position in Simulations Plus by 14.3% during the 4th quarter. US Bancorp DE now owns 5,687 shares of the technology company's stock worth $159,000 after acquiring an additional 713 shares during the last quarter. Finally, Barclays PLC grew its position in Simulations Plus by 2.7% during the 4th quarter. Barclays PLC now owns 29,229 shares of the technology company's stock worth $815,000 after acquiring an additional 756 shares during the last quarter. 78.08% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have issued reports on SLP shares. Wall Street Zen raised Simulations Plus from a "sell" rating to a "hold" rating in a report on Monday, April 28th. KeyCorp upped their price objective on Simulations Plus from $32.00 to $40.00 and gave the stock an "overweight" rating in a report on Wednesday, April 16th. Finally, William Blair reaffirmed an "outperform" rating on shares of Simulations Plus in a report on Tuesday, June 3rd. Two investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $50.00.

Insider Buying and Selling

In related news, Director Walter S. Woltosz sold 20,000 shares of the firm's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $33.51, for a total transaction of $670,200.00. Following the sale, the director now owns 3,344,157 shares of the company's stock, valued at approximately $112,062,701.07. This trade represents a 0.59% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 19.40% of the stock is currently owned by company insiders.

Simulations Plus Price Performance

Shares of SLP stock traded down $0.21 during trading hours on Tuesday, reaching $27.22. The company had a trading volume of 330,634 shares, compared to its average volume of 227,062. The company has a 50 day moving average of $30.75 and a 200 day moving average of $30.36. The firm has a market cap of $547.42 million, a price-to-earnings ratio of 68.05 and a beta of 0.97. Simulations Plus, Inc. has a 1-year low of $23.01 and a 1-year high of $50.11.

Simulations Plus (NASDAQ:SLP - Get Free Report) last posted its quarterly earnings results on Thursday, April 3rd. The technology company reported $0.31 earnings per share for the quarter, beating analysts' consensus estimates of $0.25 by $0.06. The company had revenue of $22.43 million for the quarter, compared to the consensus estimate of $21.93 million. Simulations Plus had a return on equity of 6.84% and a net margin of 10.97%. The firm's quarterly revenue was up 22.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.20 EPS. As a group, sell-side analysts forecast that Simulations Plus, Inc. will post 1.09 EPS for the current fiscal year.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.